Amperometric l-lysine determination biosensor amplified with l-lysine oxidase nanoparticles and graphene oxide nanoparticles

Nanomaterial-based electrochemical sensors for detection of amino acids

Amino acids are the building blocks of proteins and muscle tissue. They also play a significant role in physiological processes related to energy, recovery, mood, muscle and brain function, fat burning and stimulating growth hormone or insulin secretion. Accurate determination of amino acids in biological fluids is necessary because any changes in their normal ranges in the body warn diseases like kidney disease, liver disease, type 2 diabetes and cancer. To date, many methods such as liquid chromatography, fluorescence mass spectrometry, etc. have been used for the determination of amino acids. Compared with the above techniques, electrochemical systems using modified electrodes offer a rapid, accurate, cheap, real-time analytical path through simple operations with high selectivity and sensitivity. Nanomaterials have found many interests to create smart electrochemical sensors in different application fields e.g. biomedical, environmental, and food analysis because of their exceptional properties. This review summarizes recent advances in the development of nanomaterial-based electrochemical sensors in 2017-2022 for the detection of amino acids in various matrices such as serum, urine, blood and pharmaceuticals.

A Methodical Review on the Applications and Potentialities of Using Nanobiosensors for Disease Diagnosis

Presently, with the introduction of nanotechnology, the evolutions and applications of biosensors and/or nanobiosensors are becoming prevalent in various scientific domains such as environmental and agricultural sciences as well as biomedical, clinical, and healthcare sciences. Trends in these aspects have led to the discovery of various biosensors/nanobiosensors with their tremendous benefits to mankind. The characteristics of the various biosensors/nanobiosensors are primarily based on the nature of nanomaterials/nanoparticles employed in the sensing mechanisms. In the last few years, the identification, as well as the detection of biological markers linked with any form of diseases (communicable or noncommunicable), has been accomplished by several sensing procedures using nanotechnology vis-à-vis biosensors/nanobiosensors. Hence, this study employs a systematic approach in reviewing some contemporary developed exceedingly sensitive nanobiosensors alongside their biomedical, clinical, or/and healthcare applications as well as their potentialities, specifically for the detection of some deadly diseases drawn from some of the recent publications. Ways forward in the form of future trends that will advance creative innovations of the potentialities of nanobiosensors for biomedical, clinical, or/and healthcare applications particularly for disease diagnosis are also highlighted.

A comprehensive review of methods for determination of l-lysine with detailed description of biosensors

l-lysine being one of the essential amino acids is not produced by the body, but is obtained through diet. l-lysine determination is important in the food and pharmaceutical industries as well as have medical and diagnostic applications. The normal l-lysine levels in a healthy human serum sample is 150 to 250 μmol/l. There is imbalance in l-lysine levels in certain diseased conditions. So, it could be a biomarker for diagnosis. Various basic methods are available for the determination of l-lysine such as colorimetric, radioisotope dilution, chromatographic, fluorometric and voltammetric methods. These methods have certain disadvantages like sample pretreatment, costly, time consuming and requirement of skilled personnel. These drawbacks are overcome by the use of biosensors due to their high sensitivity, stability and specificity. The present review article discusses about the principles, merits and demerits of the various analytic methods for determination of l-lysine with special emphasis on biosensors. l-lysine biosensors work ideally under the optimum pH 5 to 10, potential range -0.05 to 1.5 V, temperature 25 to 40 °C, with linear range 0.01 to 5500 μM, detection limit 0.000004 to 650 μM and response time 2 to 300 s. The sensor had storage stability between 14 and 200 days.

A comprehensive review on the applications of nano-biosensor-based approaches for non-communicable and communicable disease detection

The outstretched applications of biosensors in diverse domains has become the reason for their attraction for scientific communities. Because they are analytical devices, they can detect both quantitative and qualitative biological components through the generation of detectable signals. In the recent past, biosensors witnessed significant changes and developments in their design as well as features. Nanotechnology has revolutionized sensing phenomena by increasing biodiagnostic capacity in terms of specificity, size, and cost, resulting in exceptional sensitivity and flexibility. The steep increase of non-communicable diseases across the world has emerged as a matter of concern. In parallel, the abrupt outbreak of communicable diseases poses a serious threat to mankind. For decreasing the morbidity and mortality associated with various communicable and non-communicable diseases, early detection and subsequent treatment are indispensable. Detection of different biological markers generates quantifiable signals that can be electrochemical, mass-based, optical, thermal, or piezoelectric. Speculating on the incumbent applicability and versatility of nano-biosensors in large disciplines, this review highlights different types of biosensors along with their components and detection mechanisms. Moreover, it deals with the current advancements made in biosensors and the applications of nano-biosensors in detection of various non-communicable and communicable diseases, as well as future prospects of nano-biosensors for diagnostics.

An Overview on SARS-CoV-2 (COVID-19) and Other Human Coronaviruses and Their Detection Capability via Amplification Assay, Chemical Sensing, Biosensing, Immunosensing, and Clinical Assays

A novel coronavirus of zoonotic origin (SARS-CoV-2) has recently been recognized in patients with acute respiratory disease. COVID-19 causative agent is structurally and genetically similar to SARS and bat SARS-like coronaviruses. The drastic increase in the number of coronavirus and its genome sequence have given us an unprecedented opportunity to perform bioinformatics and genomics analysis on this class of viruses. Clinical tests like PCR and ELISA for rapid detection of this virus are urgently needed for early identification of infected patients. However, these techniques are expensive and not readily available for point-of-care (POC) applications. Currently, lack of any rapid, available, and reliable POC detection method gives rise to the progression of COVID-19 as a horrible global problem. To solve the negative features of clinical investigation, we provide a brief introduction of the general features of coronaviruses and describe various amplification assays, sensing, biosensing, immunosensing, and aptasensing for the determination of various groups of coronaviruses applied as a template for the detection of SARS-CoV-2. All sensing and biosensing techniques developed for the determination of various classes of coronaviruses are useful to recognize the newly immerged coronavirus, i.e., SARS-CoV-2. Also, the introduction of sensing and biosensing methods sheds light on the way of designing a proper screening system to detect the virus at the early stage of infection to tranquilize the speed and vastity of spreading. Among other approaches investigated among molecular approaches and PCR or recognition of viral diseases, LAMP-based methods and LFAs are of great importance for their numerous benefits, which can be helpful to design a universal platform for detection of future emerging pathogenic viruses.